Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer Programs
Published: | Updated:
Launching DTC models requires navigating regulatory and licensing rules.
Spreeha Choudhury, JD, PharmD
Advertisement
Articles by Spreeha Choudhury, JD, PharmD
The idea of denying people proven medicines in the name of research has a dark legacy in this country.
Advertisement
Latest Updated Articles
Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer ProgramsPublished: October 10th 2025 | Updated: October 17th 2025
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5